Search
CannaLean Biotechs
CannaLean Biotechs is a clinical-stage biotechnology company developing proprietary, cannabinoid-based therapeutics designed to address widespread metabolic disorders. By utilizing an IP-protected formulation that combines CBD with specialized natural compounds like chitosan, the company targets hyperlipidemia—specifically reducing high cholesterol and triglyceride levels. Backed by Clalit Health Services (via its tech transfer arm, Mor Rese...
Source of information:
cannaleanbio.com
Add to My List
Key Executives
David Bassa
Founder and Chief Executive Officer
Guy Defrin
Chief Operating Officer
Industries